JESSICA DOSSEY: Open Payments
NPI 1619759925 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,304 in 91 payments from 12 companies in 2025. Trend: 2023 $222 · 2024 $2,531 · 2025 $2,304
Food & beverage: $2,153Education: $85Consulting: $66
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $727 |
| Regeneron Healthcare Solutions, Inc. | 23 | $628 |
| GENZYME CORPORATION | 15 | $385 |
| GlaxoSmithKline, LLC. | 12 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| ADMA BioManufacturing LLC | 5 | $66 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $62 |
| Amgen Inc. | 2 | $39 |
| CSL Behring | 1 | $27 |
Products named: DUPIXENT, AIRSUPRA, FASENRA, TEZSPIRE, TRELEGY ELLIPTA, CUVITRU, NEFFY, NUCALA.
Industry payments across NY — which companies pay providers there.
